← All articles

Liposomal Vitamin C vs Ascorbic Acid: What Human Trials Measured

Short answer: In most human trials, liposomal vitamin C raised blood levels more than plain ascorbic acid at the same dose. In one 500 mg crossover trial the gain was about 21% over 24 hours.

NAN HEALTH Editorial, updated October 22, 2026. 5 min read. How we write

In this articleLiposomal Vitamin CSupports immunity and healthy skin* View →
Липосомальный витамин C vs аскорбинка — подсолнух, семечки и подсолнечное масло на льне, метафора подсолнечных фосфолипидов как carrier нашего liposomal C

What liposomal and plain ascorbic acid are

Liposomal vitamin C is ascorbic acid wrapped in tiny fat bubbles, and several human trials have compared it head to head with the plain form.

Ascorbic acid is the standard form of vitamin C, the one in most tablets and in fruit. Vitamin C helps form collagen and improves iron absorption from food, and it works as an antioxidant.* MedlinePlus[4] notes the body cannot make or store it.

A liposomal product wraps vitamin C in a shell of phospholipids, which are fat molecules from sources such as sunflower or soy lecithin. A liposome is a tiny bubble with a fatty wall and a watery center. The idea is to change how the vitamin passes through the gut.

Whether it does is a question for blood measurements. That is what the trials below checked.

The 500 mg trial in 27 adults

This is the closest match to a single-capsule dose. A 2024 trial[2] gave each person placebo, standard vitamin C and liposomal vitamin C on separate days.

Who took part: 27 healthy adults, average age about 36.

Dose: a single 500 mg dose of each form, with blood drawn over 24 hours.

What changed: peak plasma level was about 27% higher and total exposure over 24 hours about 21% higher with the liposomal form. In white blood cells the gains were about 20% and 8%.

The catch: one dose, healthy people, and 24 hours of sampling.

For reference, our liposomal vitamin C has 500 mg of vitamin C per capsule.

How that trial was set up

The design matters, because it is what makes the comparison fair. The trial was randomized and double-blind, so neither the volunteers nor the staff knew which capsule was which.

It was also a crossover trial. That means every person took all three products, in a different order, with at least 3 days between sessions. Each person acts as their own comparison, which cancels out differences between individuals.

Volunteers avoided vitamin C foods and drinks before and during the sessions and ate standardized meals. Blood was drawn 11 times after dosing, from 30 minutes to 24 hours. Both vitamin C forms peaked at about 4 hours.

The catch: only one liposomal product was tested, so the result cannot be applied to every product with the same label.

A larger dose in 11 adults

A 2016 study[3] tested 4 g of vitamin C, a much higher amount than a typical capsule.

Who took part: 11 overweight or obese adults aged 45 to 70.

What changed: liposomal vitamin C gave higher blood levels than the unencapsulated form at 2, 3 and 4 hours. Total exposure was 10.3 versus 7.6 mg/dL·h. Intravenous vitamin C gave the highest levels of all.

The catch: a very small group and a single dose.

What a 2025 review of 10 trials found

A 2025 scoping review[1] by an independent researcher screened 321 studies. It kept 10 that compared liposomal and non-liposomal vitamin C in people.

  • Nine of the 10 found higher blood uptake with the liposomal form. One did not.
  • Peak levels were 1.2 to 5.4 times higher, and total exposure 1.3 to 7.2 times higher.
  • Doses ranged from 0.15 to 10 g, so results varied widely.

The author concluded that liposomal vitamin C does appear to give greater plasma availability in short-term studies. Most trials were randomized crossover designs in healthy adults, with group sizes from 5 to 27.

The catch: every study had industry funding or company-employed authors. Few measured cell uptake or health effects. The review asks for studies of urinary elimination, cellular uptake and biological effects, and for participants with low starting vitamin C status.

Nine of ten studies showed higher uptake and one did not, so a measured gain in blood levels is a reasonable expectation in short studies. At 500 mg, the size is modest rather than dramatic.

How the two forms compare

Both forms deliver the same vitamin. The difference the trials measured is how much shows up in the blood after a dose.

Same in both: the vitamin itself, its role in collagen formation, and its antioxidant role.*

Different: the liposomal coating, and the modest rise in blood levels seen in most head-to-head trials. Some people find plain ascorbic acid harsh on the stomach, and a liposomal form is designed to be gentler. That is a design goal, not a guarantee for everyone.

A form that raised blood levels more at the same dose in most trials makes sense for a person who wants a capsule rather than a larger tablet. The product card below shows what one such capsule contains.

Cautions and the upper limit

Vitamin C from supplements can upset the stomach at high amounts. MedlinePlus[4] lists stomach upset and diarrhea as high-dose effects, and kidney stones as a rare possibility. It says large supplemental amounts are not recommended during pregnancy.

Check with your doctor first if you:

  • have had kidney stones or have stomach problems
  • are pregnant or breastfeeding
  • are giving vitamin C to a child
  • take any medication

MedlinePlus states that amounts above 2,000 mg a day are not recommended. For reference, it lists the adult RDA as 90 mg for men and 75 mg for women.

The two forms at a glance

Plain ascorbic acid Liposomal
What it is Standard vitamin C Vitamin C in phospholipid shell
Blood level, 500 mg trial Baseline for comparison About 21% higher over 24 h
Trials comparing them Control arm 10 in a 2025 review
Evidence limits Long track record Industry-funded, short studies